Abstracts tagged "Intervention"

Abstract Number: 83 • 2016 ACR/ARHP Annual Meeting
A Qualitative Study Exploring Participants’ Perception of the Making It Work Program, an Online Program to Help People with Inflammatory Arthritis Maintain Employment
Xi yuan Li^1,2, Pam Rogers¹, Catherine L. Backman^1,3, Charles H. Goldsmith^4,5, Monique Gignac^6,7, Linda Li^1,8, John Esdaile^1,9 and Diane Lacaille^1,9, ¹Rheumatology, Arthritis Research Canada, Richmond, BC, Canada, ²Department of Cellular & Physiological Sciences, The University of British Columbia, Vancouver, BC, Canada, ³Department of Occupational Science & Occupational Therapy, The University of British Columbia, Vancouver, BC, Canada, ⁴Health Sciences, Simon Fraser University, Burnaby, BC, Canada, ⁵The University of British Columbia, Vancouver, BC, Canada, ⁶Institute of Work and Health, Toronto, ON, Canada, ⁷University of Toronto, Toronto, ON, Canada, ⁸Department of Physical Therapy, The University of British Columbia, Vancouver, BC, Canada, ⁹Department of Medicine, Division of Rheumatology, The University of British Columbia, Vancouver, BC, Canada
Background/Purpose: Health services addressing employment needs for people with arthritis are lacking. To address this need, we developed the Making it Work (MiW) program, an…
Abstract Number: 524 • 2016 ACR/ARHP Annual Meeting
A Self-Determination Theory Based Intervention to Increase Levels of Cardiorespiratory Fitness, Self-Determined Motivation, Physical Activity and Improve Health Outcomes Among Patients Living with Rheumatoid Arthritis
Joan Duda¹, Sally Fenton^1,2, Jet Veldhuijzen van Zanten^2,3, George Metsios^2,4, Peter Rouse⁵, Nikos Ntoumanis⁶, Chen-an Yu⁷, Yiannis Koutedakis⁸ and George D. Kitas^1,2, ¹School of Sport, Exercise and Rehabilitation, University of Birmingham, Birmingham, United Kingdom, ²Department of Rheumatology, Russells Hall Hospital, Dudley Group of Hospitals NHS Foundation Trust, Dudley, United Kingdom, ³University of Birmingham, Birmingham, United Kingdom, ⁴Department of Physical Activity Exercise and Health, University of Wolverhampton, Walsall, United Kingdom, ⁵Department for Health, University of Bath, Bath, United Kingdom, ⁶School of Psychology & Speech Pathology, Curtin University, Perth, Australia, ⁷School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, Birmingham, United Kingdom, ⁸University of Wolverhampton, Wolverhampton, United Kingdom
Background/Purpose: Rheumatoid arthritis (RA) may cause joint damage leading to physical dysfunction and associates with increased cardiovascular (CV) risk. Regular physical activity (PA) can attenuate…
Abstract Number: 141 • 2015 ACR/ARHP Annual Meeting
Improved Follow-up of Hypertension in Rheumatology Patients: Results of a Pilot
Christie M. Bartels¹, Edmond Ramly², Heather Johnson³, Yingqi Zhao¹, Zhanhai Li⁴, Patrick McBride³, Kristin Steffen Lewicki¹ and Diane Lauver⁵, ¹Department of Medicine, University of Wisconsin (UW) School of Medicine and Public Health (SMPH), Madison, WI, ²Industrial and Systems Engineering, University of Wisconsin-Madison College of Engineering, Madison, WI, ³Cardiology/Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, ⁴University of Wisconsin (UW) School of Medicine and Public Health (SMPH), Madison, WI, ⁵University of Wisconsin-Madison School of Nursing, Madison, WI
Background/Purpose: Hypertension is the most common and most modifiable cardiovascular disease (CVD) risk factor, yet it is uncontrolled in ½ of US adults. Hypertension management…
Abstract Number: 790 • 2015 ACR/ARHP Annual Meeting
An Intervention to Improve Quality of Life for African-American Lupus Patients
Edith M. Williams¹, Johnese Bostic², Alyssa Adkins³, Larisa Bruner², Jiajia Zhang², Diane L. Kamen⁴ and Jim Oates⁴, ¹Institute for Partnerships to Eliminate Health Disparities, University of South Carolina, Columbia, SC, ²University of South Carolina, Columbia, SC, ³University of South Carolina, Greenville, SC, ⁴Medicine, Medical University of South Carolina, Charleston, SC
Background/Purpose: The Intervention to Improve Quality of life for African-AmericaN lupus patients (IQAN) Project is designed to examine whether a uniquely tailored intervention program can…
Abstract Number: 2108 • 2015 ACR/ARHP Annual Meeting
A Pragmatic Cluster-Randomized Controlled Trial of an Automated, Pharmacy-Based Intervention to Optimize Allopurinol Therapy in Gout
Ted R. Mikuls¹, T C Cheetham², Nazia Rashid², Gerald D. Levy³, Artak Kerimian⁴, KJ Low², Brian Coburn⁵, David T. Redden⁶, S. Louis Bridges Jr.⁷, Kenneth G. Saag⁶ and Jeffrey R. Curtis⁷, ¹Medicine, University of Nebraska Medical Center, Omaha, NE, ²Pharmacy Analytical Services, Kaiser Permanente Southern California, Downey, CA, ³Rheumatology, Kaiser Permanente Southern California, Downey, CA, ⁴Ambulatory Care Pharmacy, Kaiser Permanente Southern California, Downey, CA, ⁵Internal Medicine - Rheumatology, University of Nebraska Medical Center, Omaha, NE, ⁶University of Alabama at Birmingham, Birmingham, AL, ⁷Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Gout is a common form of inflammatory arthritis, often treated with allopurinol as a first-line urate lowering therapy. We have designed a large…
Abstract Number: 2194 • 2015 ACR/ARHP Annual Meeting
Anticoagulation and Longterm Outcomes in Patients with Renal Artery Stenosis and Antiphospholipid Syndrome
Alina Casian¹, Shirish Sangle (joint 1st author)², Sotiria Manoustathopoulou³ and David P. D'Cruz⁴, ¹Louise Coote Lupus Unit, Guy's and St Thomas' Hospital, London, UK, London, United Kingdom, ²Louise Coote Lupus Unit, Guy's and St. Thomas' Hospital, London, United Kingdom, ³Department of Medicine, St. Thomas' Hospital, London, United Kingdom, ⁴Louise Coote Lupus Unit, Guy's and St Thomas' Hospital, London, United Kingdom
Background/Purpose: Our previous data showed renal artery stenosis (RAS) is more prevalent in antiphospholipid syndrome(APS)(26%) compared to the general hypertensive population(8%),and anticoagulation with INR>=3 was…
Abstract Number: 2382 • 2015 ACR/ARHP Annual Meeting
An Outsourced Health-Enhancing Physical Activity Program for People with Rheumatoid Arthritis. Exploration of the Maintenance Phase
Christina H. Opava¹, Birgitta Nordgren¹, Cecilia Fridén¹, Ingrid Demmelmaier¹, Gunnar Bergström², Ingrid E. Lundberg³, Alyssa B. Dufour^1,4, Thomas Nessen¹ and PARA Study Group, ¹Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Huddinge, Sweden, ²Institute of Environmental Medicine, Unit of Intervention and Implementation Research, Karolinska Institutet, Stockholm, Sweden, ³Karolinska University Hospital, Rheumatology Unit, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden, ⁴Institute for Aging Research, Hebrew SeniorLife, Harvard Medical School & Beth Israel Deaconess Medical Center, Boston, MA
Background/Purpose: Health-enhancing physical activity (HEPA), i.e. at least 150 weekly minutes of moderate-intensity and at least twice-weekly muscle-strengthening activities, is recommended for every adult. Long-term studies on HEPA…
Abstract Number: 3185 • 2015 ACR/ARHP Annual Meeting
A Cluster-Randomized Trial of a Behavioral Intervention to Incorporate a Treat-to-Target Approach in the Clinical Care of Rheumatoid Arthritis Patients in the United States
Leslie Harrold^1,2, George W. Reed^1,2, J. Timothy Harrington³, Christine J. Barr¹, Katherine C. Saunders¹, Allan Gibofsky⁴, Eric M. Ruderman⁵, Tmirah Haselkorn⁶, Jeffrey D. Greenberg^1,7, Ani John⁶ and Joel M. Kremer⁸, ¹Corrona, LLC, Southborough, MA, ²University of Massachusetts Medical School, Worcester, MA, ³Joiner Associates, LLC, Madison, WI, ⁴Hospital for Special Surgery, New York, NY, ⁵Medicine, Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, ⁶Genentech, Inc, South San Francisco, CA, ⁷NYU School of Medicine, New York, NY, ⁸Albany Medical College and The Center for Rheumatology, Albany, NY
Background/Purpose: We report the results of a cluster-randomized behavioral intervention trial designed to assess the impact of implementing a treat-to-target (T2T) approach vs usual care…
Abstract Number: 3270 • 2015 ACR/ARHP Annual Meeting
Correction of Limb Length Inequality in Adults with Knee or Hip Symptoms: A Pilot Study
Yvonne M. Golightly¹, Michael T. Gross², Amanda Nelson³, Leigh F. Callahan⁴ and Joanne M. Jordan⁴, ¹Epidemiology, University of North Carolina, Chapel Hill, NC, ²University of North Carolina, Chapel Hill, NC, ³Division of Rheumatology, Allergy, and Immunology and Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC, ⁴Thurston Arthritis Research Center, University of North Carolina, Chapel Hill, NC
Background/Purpose: Limb length inequality (LLI; paired lower extremities of unequal length) is associated with knee and hip osteoarthritis (OA) and symptoms consistent with OA (pain,…
Abstract Number: 1330 • 2014 ACR/ARHP Annual Meeting
The Efficacy of a Multidisciplinary Intervention Strategy for the Treatment of Benign Joint Hypermobility Syndrome (BJHS) in Childhood: A Randomized, Single Center Parallel Group Trial
Peter Bale¹, Vicky Easton², Holly Bacon², Emma Jerman³, Kate Armon⁴ and Alex J Macgregor^1,5, ¹School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, United Kingdom, ²Paediatric Physiotherapy Department, Norfolk and Norwich University Hospital, Norwich, United Kingdom, ³Occupational Therapist, Norwich, United Kingdom, ⁴Paediatric Rheumatology, Jenny Lind Children's Hospital, Norfolk and Norwich University Hospital, Norwich, United Kingdom, ⁵Rheumatology, Norfolk and Norwich University Hospital, Norwich, United Kingdom
Background/Purpose: Joint hypermobility is common in childhood and can be associated with musculoskeletal pain and dysfunction. Current management is delivered by a multidisciplinary team but…
Abstract Number: 1092 • 2014 ACR/ARHP Annual Meeting
Does Arthritis Status Predict Starting or Stopping Work over a 2-Year Period?
Kristina A. Theis¹, Miriam Cisternas² and Louise Murphy³, ¹Athritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ²MGC Data Services, San Diego, CA, ³Division of Population Health, Centers for Disease Control and Prevention, Atlanta, GA
Background/Purpose Employment is linked to prosperity, identity, and the ability to contribute to society. Lower employment is well documented among adults with arthritis, but less…
Abstract Number: 885 • 2014 ACR/ARHP Annual Meeting
A 2-Week Single-Blind, Randomized, 3-Arm Proof of Concept Study of the Effects of Secukinumab (anti-IL17 mAb), Canakinumab (anti-IL-1 b mAb), or Corticosteroids on Initial Disease Activity Scores in Patients with PMR, Followed By an Open-Label Extension to Assess Safety and Effect Duration
Eric L. Matteson¹, Bhaskar Dasgupta², Wolfgang A. Schmidt³, Carlo Salvarani⁴, Nagui Gendi⁵, Mauro Galeazzi⁶, Sylvie Stitah⁷, Yue Li⁸, Marie-Anne Valentin⁹, Bolan Linghu¹⁰ and Stephen J. Oliver⁷, ¹Rheumatology, Mayo Clinic, Rochester, MN, ²Rheumatology, Southend University Hospital, Essex, United Kingdom, ³Rheumatology, Immanuel Krankenhaus, Berlin, Germany, ⁴Rheumatology Unit, Arcispedale-Santa-Maria-Nuova, Reggio Emilia, Italy, ⁵Rheumatology, Basildon & Thurroch University Hospitals NHS Trust, Basildon, Essex, United Kingdom, ⁶Sezione di Reumatologia, Università di Siena, Siena, Italy, ⁷Translational Medicine, Novartis Pharma AG, Basel, Switzerland, ⁸IIS, Novartis Pharma AG, Basel, Switzerland, ⁹Biomarker Development, Novartis Pharma AG, Basel, Switzerland, ¹⁰Translational Medicine, Novartis Pharma AG, Cambridge, MA
Background/Purpose To assess the effects of a single dose of secukinumab or canakinumab in patients with new onset, untreated polymyalgia rheumatica (PMR). Methods In this…
Abstract Number: 987 • 2013 ACR/ARHP Annual Meeting
Improving Access To Subspecialty Care For Underserved Communities: A Rheumatology Patient Navigator Pilot Intervention
Candace H. Feldman¹, Gregory A. Culley², Erika Brown³, Chanele R. Assencoa², LeRoi S. Hicks⁴ and Daniel H. Solomon^3,5, ¹Rheumatology, Immunology and Allergy, Brigham and Women's Hospital,Harvard Medical School, Boston, MA, ²Family Health Center of Worcester, Inc., Worcester, MA, ³Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, ⁴Division of Hospital Medicine, UMass Memorial Medical Center, Worcester, MA, ⁵Division of Pharmacoepidemiology, Harvard Medical School, Brigham and Women's Hospital, Division of Rheumatology, Division of Pharmacoepidemiology, Boston, MA
Background/Purpose: Early and sustained access to rheumatology care can improve access to disease-modifying medications and reduce disparities in outcomes. In one state, more than one-half…
Abstract Number: 898 • 2013 ACR/ARHP Annual Meeting
Sex-Specific Employment Participation Restriction Across Occupational Groups Among Working-Age (18-64 years) U.S. Adults With and Without Arthritis
Kristina A. Theis¹ and Louise Murphy², ¹Athritis Program, Centers for Disease Control and Prevention, Atlanta, GA, ²Division of Population Health, CDC, Atlanta, GA
Background/Purpose: Previous research has shown arthritis-attributable work limitation to be high (~30%) among U.S. adults with arthritis and for employment to be ~20% lower among…
Abstract Number: 570 • 2013 ACR/ARHP Annual Meeting
In Vivo Therapeutic Success Of Microrna-155 (miR-155) Antagomir In a Mouse Model Of Lupus Pulmonary Hemorrhage
Shiyu Zhou¹, Dong Liang², Xinfang Huang³, Chunyuan Xiao³, Yuanjia Tang¹, Qian Jia³, John B. Harley^4,5 and Nan Shen^6,7,8, ¹Shanghai Institutes for Biological Sciences Chinese Academy of Sciences & Shanghai Jiao Tong University School of Medicine, Shanghai, China, ²Division of Rheumatology & the Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, ³Shanghai Institute of Rheumatology, Shanghai Institute of Rheumatology ,Renji Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China, ⁴Division of Rheumatology and The Center for Autoimmune Genomics & Etiology, University of Cincinnati, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, ⁵US Department of Veterans Affairs Medical Center, Cincinnati, OH, ⁶Rheumatology, Shanghai Institutes for Biological Sciences Chinese Academy of Sciences & Shanghai Jiao Tong University School of Medicine, Shanghai, OH, China, ⁷Division of Rheumatology & the Center for Autoimmune Genomics and Etiology (CAGE), Cincinnati Children’s Hospital Medical Center, cincinnati, OH, ⁸Shanghai Institute of Rheumatology ,Renji Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China
Background/Purpose: MiR-155 is a typical pleiotropic miRNA that participates in various aspects of immunity. Previous in vitro studies indicated that it is both a pro-inflammatory and an anti-inflammatory…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].